Narodni Ustav Dusevniho Zdravi
- Address
- lock Available on a paid plan
Neurodegenerative & Motor Disorders
The clinic at Narodni Ustav Dusevniho Zdravi is conducting studies on conditions such as multiple sclerosis, amyotrophic lateral sclerosis, and atypical Parkinsonian disorders including multiple system atrophy, progressive supranuclear palsy, and corticobasal syndrome. Trials aim to evaluate novel therapeutic approaches and assess safety of emerging treatments.
- Novel disease-modifying agents
- Neuroprotective strategies
- Symptom management
- Biomarker discovery
Emphasis on integrating advanced diagnostic techniques and patient‑centered outcomes.
Psychiatric & Treatment‑Resistant Disorders
Research at the site focuses on severe mental health illnesses such as major depressive disorder, treatment‑resistant depression, and treatment‑resistant schizophrenia. The objective is to test innovative compounds and psychedelic‑assisted therapies for rapid symptom relief and long‑term safety.
- Adjunctive antidepressant therapies
- Psychedelic‑assisted psychotherapy
- New antipsychotic agents
- Safety monitoring in chronic use
Collaboration with multidisciplinary teams ensures comprehensive evaluation of both efficacy and tolerability.
Respiratory & Comorbid Disease Research
Clinical investigations include patients with chronic obstructive pulmonary disease who also suffer from depressive symptoms, exploring how mental health interventions can improve overall wellbeing.
- Depression management in COPD
- Integrated care models
- Impact of mental health on respiratory outcomes
- Patient‑reported outcome measures
The program leverages the clinic’s expertise in both pulmonary care and psychosocial support.
Diagnostic & Therapeutic Techniques
The institution is advancing analytical, diagnostic and therapeutic equipment to support trials across multiple disease areas, enabling precise measurement of treatment effects.
- Advanced imaging biomarkers
- Digital health monitoring
- Standardized rating scales
- Safety assessment protocols
These tools are applied across neurodegenerative, psychiatric, and respiratory studies to enhance data quality.
Behavioral & Psychological Phenomena
Studies examine the underlying behavioral mechanisms and psychological phenomena associated with chronic illness, aiming to refine supportive interventions.
- Behavioral therapy integration
- Coping strategies in chronic disease
- Quality‑of‑life assessments
- Psychiatric comorbidity profiling
Findings inform personalized care pathways within the clinic’s multidisciplinary framework.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 10 therapeutic areas and 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Narodni Ustav Dusevniho Zdravi1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Narodni Ustav Dusevniho Zdravi2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Narodni Ustav Dusevniho Zdravi
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2/3, Multicenter, Randomized, Double blind, Placebo controlled Trial of the Safety and Efficacy of Flexible Doses of SEP 363856 as Adjunctive Therapy in the Treatment of Adults with Major Depressive Disorder. | Otsuka Pharmaceutical Development & Commercialization Inc. | Phase IV | Not Recruiting | Mar 2023 | Nov 2025 |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Psilocybine | 4 | Unknown | 2022-07-22 | 2025-06-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.